Table 1 Patient characteristics

Sex

  • Male

36 (62.1%)

  • Female

22 (37.9%)

Median Age [y]

52 (18 – 68)

MGMT methylation status

  • Methylated

20 (34.5%)

  • Not methylated

28 (48.3%)

  • Unknown

10 (17.2%)

Surgery

  • Yes

47 (81%)

  • No

11 (19%)

WHO grade at relapse

  • III

12 (20.7%)

  • IV

46 (79.3%)

KPS

Median 80

  • < 70

14 (24.1%)

  • ≥ 70

44 (75.9%)

Brachytherapy

  • Yes

8 (13.8%)

  • No

50 (86.2%)